Ajanta-Pharma Stock/Share Prices, Buy and Sell Ajanta-Pharma BSE Stocks

Market Snapshot

BSE Sensex: 48803.68 0.53%
BSE 500: 19483.68 0.42%
BSE 200: 6250.48 0.48%
BSE 100: 14756.53 0.48%
BSE Mid-Cap: 19923.58 -0.10%
BSE Small-Cap: 20799.69 -0.03%
BANKEX: 36473.15 1.07%
BSE IT Sector: 26747.21 0.02%
Nifty 50: 14581.45 0.53%
Nifty 500: 12237.6 0.42%
Nifty 200: 7625.05 0.49%
Nifty 100: 14719.25 0.55%
Nifty Midcap 100: 23530 0.06%
Nifty Small 100: 8171 -0.19%
Nifty IT: 26010.85 0.62%
Nifty PSU Bank: 2050.8 -1.29%

News:

Wipro Q4 PAT rises 28% YoY to ...
Tinplate Company spurts on ste...
5paisa Capital vaults after bo...
Hero MotoCorp expands digital ...
Indian Overseas Bank leads los...

Ajanta Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

15 Apr 2021 | 03:59 PM

1,703.05

-22.05 (-1.28%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

25.13%

Return (1Y)

Underperformed S&P BSE Healthcare by 27.89%
More Volatile

2.03%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 0.78%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,883

1,283

News & Announcements

Ajanta Pharma consolidated net profit rises 64.23% in the December 2020 quarter
72 days ago

Ajanta Pharma consolidated net profit rises 64.23% in the December 2020 quarter

02 - Feb - 2021 12:00 AM | 72 days ago

Net profit of Ajanta Pharma rose 64.23% to Rs 176.63 crore in the quarter ended December 2020 as against Rs 107.55 crore during the previous quarter ended December 2019. Sales rose 14.98% to Rs 748.74 crore in the quarter ended December 2020 as against Rs 651.21 crore during the previous quarter ended December 2019.
Particulars Quarter Ended
Dec. 2020 Dec. 2019 % Var.
Sales 748.74 651.21 15
OPM % 32.28 28.56 -
PBDT 244.61 199.04 23
PBT 215.47 175.44 23
NP 176.63 107.55 64
Powered by Capital Market - Live News
Ajanta Pharma to declare Quarterly Result
82 days ago

Ajanta Pharma to declare Quarterly Result

23 - Jan - 2021 12:00 AM | 82 days ago

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 2 February 2021.
Powered by Capital Market - Live News
Ajanta Pharma announces schedule of activities for proposed buyback
140 days ago

Ajanta Pharma announces schedule of activities for proposed buyback

26 - Nov - 2020 12:00 AM | 140 days ago

Ajanta Pharma announced the schedule of activities in relation to the Buyback of up to 7.35 lakh equity shares at a price of Rs 1850 per share.
Date of opening of buyback offer - 03 December 2020
Date of closing of buyback offer - 16 December 2020
Last date of receipt of the completed tender forms - 18 December 2020
Last date of settlement of bids on the stock exchange - 24 December 2020
Powered by Capital Market - Live News
Board of Ajanta Pharma recommends Interim Dividend
162 days ago

Board of Ajanta Pharma recommends Interim Dividend

04 - Nov - 2020 12:00 AM | 162 days ago

Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 03 November 2020, has recommended a Interim dividend of Rs.9.50 per share (i.e.475%), subject to the approval of the shareholders.
Powered by Capital Market - Live News

Stock Trivia

FII shareholding in Ajanta Pharma Ltd has increased by 5.86% since past 3 Months
FII shareholding in Ajanta Pharma Ltd has decreased by -6.14% since past 1 Year
GovT shareholding in Ajanta Pharma Ltd has increased by 3.01% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2020	Dec. 2019	% Var.
Sales	748.74	651.21	15
OPM %	32.28	28.56	-
PBDT	244.61	199.04	23
PBT	215.47	175.44	23
NP	176.63	107.55	64

General Notifications

My Notifications

Research Notifications

Ajanta Pharma Ltd NSE / BSE Pharmaceuticals, Mid Cap

1,703.05 -22.05 (-1.28%)

News & Announcements

Stock Trivia

Ajanta Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

1,703.05

-22.05 (-1.28%)